Theophylline
NDC 69452-267, Theophylline, tablet, extended release, from Bionpharma Inc.,.
- Product NDC
- 69452-267
- Status
- Listed
- Labeler
- Bionpharma Inc.,
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216300
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-267 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS300 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-267-20 | 69452026720 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-267-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/63517422-45a0-4e78-8505-eca054068ee9NADAC price for package 69452026720
GET /v1/drugs/nadac/69452026720
Use it
Look up 69452-267 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-267 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-267. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.